Jonas Kingo: ISTH 2026 in Paris Brings the Global Hemostasis Community Together
Jonas Kingo, CEO at Aniara Holding, shared a post on LinkedIn:
“22 days to ISTH 2026 in Paris.
We’re in the final stretch of preparation — and the excitement in the hemostasis community is real.
3,188 abstracts accepted. 6,000+ attendees expected from over 100 countries.
The full abstract book drops June 26 — one week from today.
For our team, ISTH is the highlight of the year.
It’s where the science we work with every day gets presented, debated, and advanced.
It’s where researchers and lab directors we’ve known for years compare notes in person.
And it’s where the next generation of hemostasis scientists present their first major work.
Aniara will be at Paris Expo Porte de Versailles, Pavilion 7, representing HYPHEN BioMed, 5-Diagnostics, Medicago, and Xenometrix.
If you’re going to Paris and haven’t connected with us yet — now is the time.
Our schedule fills up fast once we land.”
Stay updated with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering